First Midwest Bank Trust Division’s Acadia Pharmaceuticals ACAD Stock Holding History

First Midwest Bank Trust Division’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$221K	Sell	9,500 -2,000	-17%	-$40.2K	0.03%	351
2021 Q3	$191K	Sell	11,500 -2,877	-20%	-$55.5K	0.03%	357
2021 Q2	$351K	Sell	14,377 -52,348	-78%	-$1.18M	0.05%	309
2021 Q1	$1.72M	Buy	66,725 +46,555	+231%	+$2.05M	0.24%	105
2020 Q4	$1.08M	Sell	20,170 -23,270	-54%	-$1.16M	0.16%	146
2020 Q3	$1.79M	Buy	43,440 +22,596	+108%	+$976K	0.28%	92
2020 Q2	$1.01M	Sell	20,844 -1,604	-7%	-$77K	0.16%	147
2020 Q1	$948K	Buy	22,448 +663	+3%	+$27.3K	0.17%	136
2019 Q4	$932K	Sell	21,785 -505	-2%	-$22K	0.13%	176
2019 Q3	$802K	Sell	22,290 -18,347	-45%	-$556K	0.12%	190
2019 Q2	$1.09M	Sell	40,637 -36,171	-47%	-$924K	0.15%	156
2019 Q1	$2.06M	Sell	76,808 -88,558	-54%	-$2.07M	0.28%	96
2018 Q4	$2.67M	Buy	165,366 +100,354	+154%	+$1.95M	0.4%	62
2018 Q3	$1.35M	Buy	+65,012	New	+$1.02M	0.18%	135
2016 Q3	–	Sell	-40,344	Closed	-$1.31M	–	439
2016 Q2	$1.31M	Buy	40,344 +10,124	+34%	+$339K	0.16%	178
2016 Q1	$845K	Buy	+30,220	New	+$659K	0.11%	197

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Midwest Bank Trust Division's ACAD Position: Q4 2021 in Review

First Midwest Bank Trust Division reduced its Acadia Pharmaceuticals (ACAD) stake by 17% in Q4 2021, selling an estimated $40.2K and leaving 9,500 shares worth $221K. The position accounts for 0.03% of the portfolio, ranked #351.

First Midwest Bank Trust Division first reported a position in ACAD in Q1 2016 and has held it in 16 quarters since. The position peaked at $2.67M in Q4 2018. 247 funds tracked by Wall St. Rank hold ACAD as of Q4 2021.

First Midwest Bank Trust Division held 9,500 shares of Acadia Pharmaceuticals worth $221K as of Q4 2021.
First Midwest Bank Trust Division sold 2,000 Acadia Pharmaceuticals shares in Q4 2021, an estimated $40.2K.
Acadia Pharmaceuticals made up 0.03% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #351 holding.
First Midwest Bank Trust Division first reported a position in Acadia Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
First Midwest Bank Trust Division's Acadia Pharmaceuticals position peaked at $2.67M in Q4 2018.
247 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.